GERON CORPORATION INVESTOR ALERT: Girard Gibbs Investigates Potential Securities Law Violations
March 28 2018 - 6:29PM
Business Wire
Girard Gibbs LLP is investigating claims on behalf of investors
of Geron Corporation (NASDAQ:GERN) involving possible securities
law violations. Specifically, our investigation focuses on
allegations that Geron may have issued materially misleading
business information to the investing public.
To speak privately with an attorney regarding this class
action lawsuit investigation, click here.
On March 27, 2018, STAT, a news organization focused on medical
industry reporting, published an article alleging that Geron’s
recent stock gains were due to “flimsy” claims regarding the
efficacy of Imetelstat, Geron’s experimental treatment for
myelofibrosis. The report further states that available data for
Imetelstat does not support Geron’s representations about the
drug’s efficacy.
Following the publication of the STAT article on March 27, 2018,
shares of Geron dropped by more than 13% to close at $5.15 per
share. The stock continued to plummet into the next day of trading,
closing down 17.86% on March 28, 2018, and causing significant harm
to investors.
If you purchased or acquired shares of Geron Corporation and
would like to speak privately with a securities attorney to learn
more about the investigation and your legal rights, visit our
website or contact the securities team directly at (800)
254-9493.
Girard Gibbs LLP is one of the nation’s leading firms
representing individual and institutional investors
in securities litigation to correct abusive corporate
governance practices, breaches of fiduciary duty, and proxy
violations. The firm has recovered over a billion dollars for its
clients against some of the world’s largest corporations, and has
earned Tier-1 rankings and been named in the U.S. Lawyers –
Best Law Firms list for five consecutive years.
This press release may constitute Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180328006215/en/
Girard Gibbs LLPEileen Epstein,
510-350-9728eje@classlawgroup.com
Geron (NASDAQ:GERN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Sep 2023 to Sep 2024